Atlas Trials

Homologous Recombination Deficiency

20 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Homologous Recombination Deficiency

RecordFirmDate
HRD and Resistance to PAPPi in EOC Patients (NCT05310370)Lei Li2022-03-26
Olaparib in Patients With HRD Malignant Mesothelioma (NCT04515836)University of Chicago2021-02-19
A Training Set for the HRD Model in EOC (NCT04651933)Lei Li2020-11-26
A Study on Association Between HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer (NCT04651920)Lei Li2020-11-26
Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer (NCT04556071)Xiaoxiang Chen2020-11-06
Homologous Recombination Deficiency Status in Epithelial Ovarian Cancer (NCT04190667)Lei Li2019-12-07
Basket Trial of IDX-1197, a PARP Inhibitor, in Patients With HRR Mutated Solid Tumors (VASTUS) (NCT04174716)Idience Co., Ltd.2019-11-06
Epacadostat and Pembrolizumab in Treating Participants With Advanced Pancreatic Cancer (NCT03432676)M.D. Anderson Cancer Center2019-07-31
Functional Analysis of BRCAness (NCT04780945)Leiden University Medical Center2019-01-21
Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency (NCT03442556)University of Washington2018-08-24
Niraparib Plus Carboplatin in Patients With Homologous Recombination Deficient Advanced Solid Tumor Malignancies (NCT03209401)Georgetown University2017-10-13

Track Homologous Recombination Deficiency automatically

Every clearance here is in the API, with alerts when new ones post.